X @Bloomberg

Eisai and Biogen received US regulatory approval for a new self-injected form of their Alzheimer’s drug Leqembi, in a move that could make a complicated treatment regimen more convenient for patients taking the drug long term https://t.co/3TkmmUjTiT ...